<DOC>
	<DOCNO>NCT00521599</DOCNO>
	<brief_summary>This study placebo-controlled study 8-weeks double-blind treatment mometasone furoate dry powder inhaler ( MF DPI ) 200 mcg twice daily ( BID ) use two different inhaler , precede Screening Period 2 week open-label treatment one inhalation MF DPI 200 mcg twice daily corticosteroid-dependent asthmatic subject . The objective study evaluate therapeutic equivalency 100 mcg 200 mcg MF DPIs provide total daily dose ( 400 mcg/day ) .</brief_summary>
	<brief_title>A Study Equivalent Effectiveness 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers Moderate Asthmatics ( Study P04828 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>18 year age , either sex , race , diagnosis asthma least 12 month ' duration . Must stable regimen medium daily dose ICS least 4 week immediately prior Screening . Medium daily dos ICS : &gt; 500 1000 mcg beclomethasone CFC &gt; 250 500 mcg beclomethasone HFA &gt; 600 1000 mcg budesonide DPI &gt; 1000 2000 mcg flunisolide &gt; 250 500 mcg fluticasone 400 mcg MF &gt; 1000 2000 mcg triamcinolone acetonide . Must document reversibility test obtain within 12 month prior sign inform consent form . Otherwise , document diagnosis asthma ensure subject 's responsiveness bronchodilator , one follow method use Screening Visit , thereafter , prior Baseline Visit : An increase absolute FEV1 &gt; =12 % &gt; =200 mL within 30 minute administration 4 puff albuterol . A PEF variability &gt; 20 % , express percent best low morning prebronchodilator PEF least 1 week . A diurnal variation PEF &gt; 20 % base difference prebronchodilator AM value postbronchodilator value evening , express percentage mean daily PEF value day Runin Period . At Screening Baseline , subject 's FEV1 must &gt; =60 % predict , restricted medication withhold appropriate interval . If , base clinical judgment investigator , harm change subject 's asthma therapy , subject LABAs must willing discontinue LABA transfer openlabel treatment MF MDI 200 mcg BID 2 week prior randomization . Clinical laboratory test conduct Screening Visit must within normal limit clinically acceptable investigator/sponsor subject instruct start use openlabel MF DPI runin medication . A chest xray perform Screening Visit type chest image within 12 month prior Screening Visit must clinically acceptable investigator . A female childbearing potential must use medically acceptable , adequate form birth control . This include : 1 ) hormonal contraceptive prescribe physician ( oral combine , hormonal implant ) ; 2 ) medically prescribed IUD ; 3 ) condom combination spermicide ( doublebarrier method ) ; 4 ) monogamous relationship male partner vasectomy . The subject must start birth control method least 3 month prior Screening ( exception condom combination spermicide ) , must agree continue use duration study . A subject childbearing potential currently sexually active must agree consent use medically acceptable method become sexually active course study . Women surgically sterilize least 1 year postmenopausal consider childbearing potential . A subject childbearing potential must negative serum pregnancy test Screening . A change absolute FEV1 &gt; 20 % time Screening Visit include Baseline Visit . A clinical asthma exacerbation ( define deterioration asthma result emergency treatment , hospitalization , treatment additional , exclude asthma medication time Screening Visit include Baseline Visit ) . Treatment emergency department admission hospital asthma exacerbation 12 month prior Screening . An upper low respiratory tract infection within 4 week Screening . Visits reschedule meet requirement . Evidence clinically significant oropharyngeal candidiasis Baseline without treatment . If evidence oropharyngeal candidiasis Screening and/or MF DPI Runin Period , subject may treat appropriate Baseline Visit schedule upon resolution . If evidence oropharyngeal candidiasis Baseline Visit , subject may treat appropriate visit reschedule upon resolution . A smoker exsmoker smoke within previous year cumulative smoking history &gt; 10 packyears . Requires twelve inhalation albuterol 2 treatment nebulized betaagonists 2 consecutive day Runin Period . Ever required mechanical ventilation secondary asthma exacerbation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>